关于 "Glucose Transporters" 的结果31 个结果
筛选:Metabolism×
- Ertugliflozin L-pyroglutamic acidCAS: 1210344-83-4
Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus.
- YUM70CAS: 423145-35-1
YUM70 is a potent inhibitor of glucose-regulated protein 78 (GRP78) inhibitor with an IC50 of 1.5 μM. YUM70 induces endoplasmic reticulum (ER) stress-mediated apoptosis in pancreatic cancer.Although YUM70 inhibits GRP78 enzymatic activity, it increases the expression of GRP78 by increasing the chaperone translation mechanism.
- DapagliflozinCAS: 461432-26-8
Dapagliflozin 是一种钠-葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂,是一种新型抗糖尿病药物,由于其抑制 SGLT2 介导的肾葡萄糖重吸收的能力而被批准用于治疗 T2DM。
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC36004 | Ertugliflozin L-pyroglutamic acid | 1210344-83-4 | SGLT | ||
Ertugliflozin (MK-8835, PF-04971729) L-pyroglutamic acid is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2) with IC50 of 0.877 nM for h-SGLT2. Ertugliflozin has the potential for the treatment of type 2 diabetes mellitus. | |||||
| GC62388 | YUM70 | 423145-35-1 | Apoptosis | ||
YUM70 is a potent inhibitor of glucose-regulated protein 78 (GRP78) inhibitor with an IC50 of 1.5 μM. YUM70 induces endoplasmic reticulum (ER) stress-mediated apoptosis in pancreatic cancer.Although YUM70 inhibits GRP78 enzymatic activity, it increases the expression of GRP78 by increasing the chaperone translation mechanism. | |||||
| GC15530 | Dapagliflozin | 461432-26-8 | SGLT | ||
Dapagliflozin 是一种钠-葡萄糖协同转运蛋白 2 (SGLT2) 抑制剂,是一种新型抗糖尿病药物,由于其抑制 SGLT2 介导的肾葡萄糖重吸收的能力而被批准用于治疗 T2DM。 | |||||
| GC16697 | fluoro-Dapagliflozin | 1181681-43-5 | SGLT | ||
A potent inhibitor of hSGLT2 | |||||
| GC43768 | Glucocerebrosides (Gaucher's spleen) | 85305-87-9 | Neuroscience | ||
A sphingolipid | |||||
| GC15605 | Ezetimibe | 163222-33-1 | Autophagy | ||
Ezetimibe是一种选择性胆固醇吸收抑制剂,对肺癌细胞(A549)和人胚肾细胞(HEK293)的IC50为50µM,对黑色素瘤细胞(A375)的IC50为30µM,作用时间均为48h。 | |||||
| GC16775 | Rotenone | 83-79-4 | Other Apoptosis | ||
Rotenone是一种线粒体电子传递链复合物 I 抑制剂,可通过增强线粒体活性氧的产生来诱导细胞凋亡。 | |||||
